InvestorsHub Logo
Followers 827
Posts 119499
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 14377

Monday, 12/07/2015 12:40:22 PM

Monday, December 07, 2015 12:40:22 PM

Post# of 20689
MNTA hires BIIB executive for COO position:

http://finance.yahoo.com/news/momenta-pharmaceuticals-appoints-matthew-p-153000611.html

Momenta Pharmaceuticals, Inc….today announced the appointment of Matt Ottmer as Chief Operating Officer.

…Mr. Ottmer most recently served as Senior Vice President, Strategy & Emerging Businesses at Biogen, Inc. where he led cross-functional assessment, prioritization, and implementation planning across a broad range of value-creating opportunities including internal capability building, alliances and in-licenses, and mergers and acquisitions. Before his promotion to Senior Vice President, Mr. Ottmer held positions of increasing responsibility at Biogen from 1999 to 2015 including Head of Tysabri Business, Chief of Staff to the CEO, President of Syntonix Pharmaceuticals, Inc. (a wholly owned subsidiary of Biogen), and Vice President, Global Operations. He received a Bachelor of Arts degree in political science from the University of Michigan and a Master’s in Business Administration from Northwestern University’s Kellogg School of Management.

MNTA hasn’t had a COO since 2010 (when Steven Brugger left to become CEO of Visterra Pharmaceuticals).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”